Independent predictors of metabolic syndrome in HIV-infected patients

AIDS Patient Care and STDs

Volumn 25, Issue 11, 2011, Pages 627-634

  Alencastro, Paulo R ^a   Fuchs, Sandra C ^a,b   Wolff, Fernando H ^a,c   Ikeda, Maria Letícia ^a,b   Brandão, Ajácio B M ^c,d   Barcellos, Nemora T ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Partenon Sanatorium Hospital   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; EDUCATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREDICTOR VARIABLE; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; VIRUS LOAD;

ADULT; AGE FACTORS; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; BRAZIL; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HIV INFECTIONS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATIENTS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 80055039774     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2010.0360     Document Type: Article

References (28)

1. Grinspoon SK. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med 2005;118:23S-28S.
2. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-A new worldwide definition. Lancet 2005;366:1059-1062. (Pubitemid 41338752)
3. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001;32:130-139. (Pubitemid 32150958)
4. De Socio GV, Martinelli C, Ricci E, et al. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: Results from the HERMES study. Int J STD AIDS 2010;21:267-272.
5. Lai S, Bartlett J, Lai H, et al. Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection. AIDS Patient Care STDs 2009;23:815-824.
6. Pullinger CR, Aouizerat BE, Gay C, et al. Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults. Metab Syndr Relat Disord;8:279-286.
7. Jerico C, Knobel H, Montero M, et al. Metabolic syndrome among HIV-infected patients: Prevalence, characteristics, and related factors. Diabetes Care 2005;28:132-137. (Pubitemid 40095795)
8. Bonfanti P, Giannattasio C, Ricci E, et al. HIV and metabolic syndrome: A comparison with the general population. J Acquir Immune Defic Syndr 2007;45:426-431. (Pubitemid 47057669)
9. Jacobson DL, Tang AM, Spiegelman D, et al. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). J Acquir Immune Defic Syndr 2006;43:458-466. (Pubitemid 44737105)
10. Hansen BR, Petersen J, Haugaard SB, et al. The prevalence of metabolic syndrome in Danish patients with HIV infection: The effect of antiretroviral therapy. HIV Med 2009;10:378-387.
11. Pao V, Lee GA, Grunfeld C. HIV therapy, metabolic syndrome, and cardiovascular risk. Curr Atheroscler Rep 2008;10:61-70. (Pubitemid 351385601)
12. Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care 2007;30: 113-119. (Pubitemid 46052508)
13. Cahn PLO, Rosales A, Cabello R, et al. Metabolic profile and cardiovascular risk factors among Latin American HIVinfected patients receiving HAART. Braz J Infect Dis 2010; 14:158-166.
14. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
15. Diehl LA, Dias JR, Paes AC, et al. [Prevalence of HIVassociated lipodystrophy in Brazilian outpatients: relation with metabolic syndrome and cardiovascular risk factors]. Arq Bras Endocrinol Metabol 2008;52:658-667.
16. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-1645.
17. Bernaards CM, Twisk JW, Snel J, Van Mechelen W, Kemper HC. Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years. Addiction 2001;96: 1653-1661.
18. Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-1395. (Pubitemid 36936159)
19. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007;116:1081-1093. (Pubitemid 47329572)
20. OBrien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: The Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996;1:55-61. (Pubitemid 126441351)
21. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
22. Adeyemi O RK, Bahk M, Badri S, Thomas-Gossain N. Metabolic Syndrome in Older HIV-Infected Patients: Data from the CORE50 Cohort. AIDS Patient Care STDs 2008;22: 941-945.
23. Squillace N, Zona S, Stentarelli C, et al. Detectable HIV viral load is associated with metabolic syndrome. J Acquir Immune Defic Syndr 2009;52:459-464.
24. Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes 2010;2:180-193.
25. Bernal E, Masiá M, Padilla S, Gutiérrez F. High-density lipoprotein cholesterol in HIV-infected patients: Evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition. AIDS Patient Care STDs 2008;22:569-575. (Pubitemid 352040053)
26. Cameron AJ, Boyko EJ, Sicree RA, et al. Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity (Silver Spring) 2008;16: 2707-2716.
27. Boodram BPM, Cox C, Tien PC, et al. Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Womens Interagency HIV Study. AIDS Patient Care and STDs 2009;23:1009-1016.
28. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53:2087-2094. (Pubitemid 38970759)